• Explore /
  • Poster
  • / Molecular characterization of clinical response in patients  with newly diagnosed acute myeloid leukemia treated with ivosidenib + azacitidine compared to placebo + azacitidine.

Molecular characterization of clinical response in patients  with newly diagnosed acute myeloid leukemia treated with ivosidenib + azacitidine compared to placebo + azacitidine.

Abstract Video & Slides Poster

Authors

Stéphane De Botton

Stéphane De Botton

Institut Gustave Roussy, Villejuif, France

Stéphane De Botton , Sung Choe , Dylan M. Marchione , Pau Montesinos , Christian Recher , Susana Vives Polo , Ewa Zarzycka , Jianxiang Wang , Giambattista Bertani , Michael Heuser , Rodrigo T. Calado , Andre C. Schuh , Su-Peng Yeh , Jianan Hui , Shuchi Sumant Pandya , Diego A. Gianolio , Scott Daigle , Courtney Denton Dinardo , Hartmut Dohner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT03173248

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7019)

DOI

10.1200/JCO.2022.40.16_suppl.7019

Abstract #

7019

Poster Bd #

250

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

Clinical and molecular characteristics of patients with AML with an exceptional response to ivosidenib.

Clinical and molecular characteristics of patients with AML with an exceptional response to ivosidenib.

First Author: Justin M. Watts

First Author: Hartmut Dohner

First Author: Koichi Takahashi

First Author: Stéphane De Botton